logo
Plus   Neg
Share
Email

Zijin Mining To Acquire Continental Gold For C$1.4 Billion Cash - Quick Facts

China's Zijin Mining Group Co., Ltd. agreed Monday to acquire all of the outstanding shares of Canada's Continental Gold Inc. at a price of C$5.50 per share in cash and all outstanding securities convertible into such common shares will also be acquired on the same basis.

The total equity value pursuant to the transaction is approximately C$1.4 billion on a fully diluted basis. The Offer Price represents a premium of 29% over Continental's 20-day volume-weighted average price as at November 29, 2019 on the Toronto Stock Exchange.

Newmont Goldcorp Corp. and directors and officers of Continental collectively holding approximately 21.5% of the outstanding Continental common shares have entered into voting support agreements to support the transaction.

The transaction has been unanimously approved by the board of directors of Continental following the unanimous recommendation of a special committee of independent directors of Continental.

The transaction is subject to approval by Continental shareholders, the receipt of certain regulatory, court and stock exchange approvals and other closing conditions customary in transactions of this nature.

Zijin would be entitled to a US$35 million termination fee and Continental would be entitled to a US$35 million reverse termination fee or may require Zijin to purchase US$35 million of Continental shares at the offer price.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Twitter has had preliminary talks with TikTok's Chinese owner ByteDance to buy the U.S. operations of the video-sharing app, the Wall Street Journal reported citing people familiar with the matter. Meanwhile, Microsoft has been the only company so far to say publicly it is pursuing TikTok. Pfizer said Friday it reached a multi-year deal with Gilead Sciences to manufacture and supply Gilead's investigational antiviral remdesivir for COVID-19 patients. Ferring Pharmaceuticals US is recalling various nasal sprays citing superpotency or amounts of desmopressin higher than specified, the U.S. Food and Drug Administration announced in a statement. The recall involves all lots on the market of DDAVP Nasal Spray 10 mcg/0.1mL, Desmopressin Acetate Nasal Spray 10 mcg/0.1mL, and STIMATE Nasal Spray 1.5 mg/mL.
RELATED NEWS
Follow RTT